RxDoctor Payments Data

Linda Esposito

Psychiatric/Mental Health · Phillipsburg, NJNPI 1639310287

Payments from drug & device makers

$1,734in general payments, 2019–2025

Across 122 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$797
  • Takeda Pharmaceuticals U.S.A., Inc.$185
  • Teva Pharmaceuticals USA, Inc.$135
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
  • Neurocrine Biosciences, Inc.$96
  • Johnson & Johnson$71
  • plus $349 from 8 others

What the payments were for

  • Food & beverage$1,734100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,734 in reported general payments places this provider in the 75th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey

Medicare billing

Part B allowed, 2024
$40,791
Medicare patients
48
Services billed
422

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine14$122,469
IngrezzaValbenazine Tosylate13$106,935
RexultiBrexpiprazole34$48,544
VraylarCariprazine Hcl29$41,358
Duloxetine Hcl108$2,535
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine52$1,835
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine29$1,783
Venlafaxine Hcl ErVenlafaxine Hcl53$1,675
Desvenlafaxine Succinate ErDesvenlafaxine Succinate47$1,530
Quetiapine Fumarate85$1,376
Ziprasidone Hcl24$1,292
Doxepin Hcl18$1,071
Fluoxetine Hcl40$978
Oxcarbazepine18$969
Escitalopram Oxalate64$921

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$135$122,46914 claims
Neurocrine Biosciences, Inc.Ingrezza$96$106,93513 claims
Otsuka America Pharmaceutical, Inc.Rexulti$71$48,54434 claims
AbbVieVraylar$797$41,35829 claims
Almatica Pharma LLCSertraline Hcl$49$9833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,212 psychiatric/mental health providers in New Jersey.

Other psychiatric/mental health in Phillipsburg

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →